Loading
Latest filing published 05 May 2021 for Protagenic Therapeutics, Inc.\new, €47k. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
One trade, one date: on 5 May 2021, Khalil Barrage disclosed an option exercise of €47k in Protagenic Therapeutics, Inc.\new. No broader history exists yet. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
1 of 1 declaration